@article{e6e1fc4d0cda44b7902743124982f0c8,
title = "Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2",
abstract = "Coronavirus disease 2019 (COVID-19) infection in patients with haematological neoplasms has been associated with increased mortality; however, many studies in this patient group were reported early in the pandemic. The authors evaluated outcomes of COVID-19 infection in patients with haematological conditions following widespread vaccination, newer viral variants and increasingly effective antiviral therapies. A 4% mortality rate was found and contemporary risk factors for hospitalisation including older age, nonvaccination or partial COVID-19 vaccination status and infection with non-Omicron strain were identified.",
keywords = "cancer, COVID-19, haematological malignancy, haematological neoplasm, vaccination",
author = "Briony Shaw and Jake Shortt and Michael Low and Benjamin Rogers and Zane Kaplan and Pasquale Fedele and Gareth Gregory and Shahla Vilcassim and Michael Gilbertson and George Grigoriadis and Stephen Opat",
note = "Funding Information: GPG is supported by a Victorian Cancer Agency Clinical Research Fellowship. Acknowledgement is made to the colleagues assisting with collating the cases of COVID‐19–positive patients in our cohort. Open access publishing facilitated by Monash University, as part of the Wiley ‐ Monash University agreement via the Council of Australian University Librarians. Publisher Copyright: {\textcopyright} 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians.",
year = "2022",
month = dec,
doi = "10.1111/imj.15954",
language = "English",
volume = "52",
pages = "2172--2175",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "12",
}
